Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. It also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.
高配当
同社は高配当銘柄であり、最新の配当性向は9.41%です。
安定配当
同社は過去5年間にわたり継続的に配当を実施しており、最新の配当性向は9.41%です。
割安
同社の最新のPEは26.80で、過去3年間の水準と比較して安値圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は351.93M株で、前四半期比で1.24%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を33.62M株保有しています。
市場活動が低調
同社への投資家の関心は低下しており、20日間の売買回転率は-0.04です。